X

Vous n'êtes pas connecté

Maroc Maroc - ZACKS.COM - All Stories - 10/07/2024 12:51

Athira (ATHA) Completes Dosing in Alzheimer's Study, Stock Up

Athira (ATHA) completes dosing the last patient in the phase II/III LIFT-AD study on fosgonimeton for treating people with mild-to-moderate Alzheimer's disease. Stock gains.

Articles similaires

Sorry! Image not available at this time

IONS Up on FDA's Breakthrough Tag for ION582 in Angelman Syndrome

zacks.com - 10/Sep 15:11

Ionis jumps as FDA grants Breakthrough Therapy status to ION582 for treating Angelman syndrome, with the phase III study now underway.

Pollution may make Alzheimer’s disease worse

knowridge.com - 12/Sep 00:11

Breathing in dirty air may do more than harm your lungs — it could also be making Alzheimer’s disease worse. A new study from the University of...

Pollution may make Alzheimer’s disease worse

knowridge.com - 12/Sep 00:11

Breathing in dirty air may do more than harm your lungs — it could also be making Alzheimer’s disease worse. A new study from the University of...

Sorry! Image not available at this time

Cognition Therapeutics Study of Zervimesine (CT1812) in Early Alzheimer’s Disease Reaches 75% Enrollment Target

mangaloremirror.com - 03/Sep 11:55

PURCHASE, N.Y., Sept. 03, 2025 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company...

Sorry! Image not available at this time

Cognition Therapeutics Study of Zervimesine (CT1812) in Early Alzheimer’s Disease Reaches 75% Enrollment Target

mangaloremirror.com - 03/Sep 11:55

PURCHASE, N.Y., Sept. 03, 2025 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company...

Sorry! Image not available at this time

Citryll begins patient dosing in phase IIa trial of CIT─013 to treat rheumatoid arthritis

pharmabiz.com - 03/Sep 22:59

Citryll, a biotech company pioneering a transformative approach to treating immune─mediated inflammatory diseases by targeting Neutrophil...

Sorry! Image not available at this time

Citryll begins patient dosing in phase IIa trial of CIT─013 to treat rheumatoid arthritis

pharmabiz.com - 03/Sep 22:59

Citryll, a biotech company pioneering a transformative approach to treating immune─mediated inflammatory diseases by targeting Neutrophil...

Air pollution may speed up Alzheimer’s damage in the brain

knowridge.com - 09/Sep 23:32

Breathing polluted air may do more than harm the lungs and heart—it may also make Alzheimer’s disease worse. A new study has found that people...

Sorry! Image not available at this time

Mediterranean-Style Diet May Help Reduce Dementia Risk: Study

zeenews.india.com - 02/Sep 11:49

Over the last few decades, researchers have learned more about the genetic and metabolic basis of Alzhet up to 80%. imer's disease and related...

Sorry! Image not available at this time

Alzheimer Disease Associated With Greater Neural Flexibility

drugs.com - 09/Sep 16:09

TUESDAY, Sept. 9, 2025 -- Alzheimer disease (AD) is associated with greater neural flexibility (NF) in older adults, according to a study published...

Les derniers communiqués